EUVIMED · CrossrefZeitschrift
Blood Science
ISSN 2543-6368 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Single-episome delivery of BOSMK with miR-142–gated KLF4 streamlines PBMC reprogramming to iPSCs
Gfi1ab-Cebpβ axis promotes eosinophilopoiesis in zebrafish
Efficacy and safety of eltrombopag in the treatment of cancer therapy–induced thrombocytopenia: a large-scale, multicenter, retrospective study in China
Sequential glofitamab and consolidative ASCT plus CAR-T therapy achieved durable remission in relapsed/refractory DLBCL
LPCAT3 is essential for leukemia progression and represents a therapeutic vulnerability in AML
Breakthroughs and challenges of CAR-T cell therapy in treating hematologic malignancies of the central nervous system
Application of next-generation sequencing in the treatment of myelodysplastic syndrome: from mechanisms to clinical practice
Primary vitreoretinal lymphoma: diagnosis, treatment, and prognosis—a review of current knowledge and future directions
Enhancing hemophilia A gene therapy by strategic F8 deletions in AAV vectors
Dual role of BCL11B in T-cell malignancies
Early megakaryocyte lineage-committed progenitors in adult mouse bone marrow
Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantation
PD-L1: expression regulation
The Evolution of Iron-Related Comorbidities and Hospitalization in Patients with Hemochromatosis: An Analysis of the Nationwide Inpatient Sample
Spatially resolved transcriptomics: advances and applications
Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia
KHSRP combines transcriptional and posttranscriptional mechanisms to regulate monocytic differentiation
Advances in measuring DNA methylation
Lymphoid-biased hematopoietic stem cells and myeloid-biased hematopoietic progenitor cells have radioprotection activity
Zebrafish for thrombocytopoiesis- and hemostasis-related researches and disorders
Intensive care unit outcomes in patients with hematological malignancy
Current status and hurdles for CAR-T cell immune therapy
Interleukin-12 supports in vitro self-renewal of long-term hematopoietic stem cells
Macrophages in leukemia microenvironment
The disruption of hematopoiesis in tumor progression
Quickly attainable and highly engrafting hematopoietic stem cells
A new platform for new promises in hematology
Successful ex vivo expansion of mouse hematopoietic stem cells
When blood development meets single-cell transcriptomics
Multifaced regulator: RNA binding proteins and their roles in hematopoiesis
EUVIMED